Skip to content

NFMS PMCF study

NFMS PMCF study -> Intrapartum non-invasive electrophysiological fetal monitoring Study - Intrapartum non-invasive electrophysiological fetal monitoring Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON61407
Enrollment
30
Registered
2025-06-19
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perinatal complications, interventions and outcome complications of the child before and during delivery, condition of the child after birth

Interventions

Eligible patients who are monitored with FSE will be included for additional registration with NFMS. NFMS uses a transabdominal, non-invasive electrode patch. This patch will be placed from the moment

Sponsors

Catharina Ziekenhuis
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Pregnant women who are in active labour -Pregnant women carrying a healthy, singleton fetus in cephalic presentation -Gestational age between 34 and 42 weeks.

Exclusion criteria

Exclusion criteria: -Maternal age below 18 years -Multiple pregnancy -Signs of fetal distress at the time of inclusion (abnormal NI-CTG requiring immediate intervention, maternal positive hepatitis B/C or HIV serology idiopathic thrombocytopenia or other fetal, maternal conditions which are a contraindication to FSE, contraindications to abdominal patch placement e.g. dermatologic diseases of the abdomen precluding preparation ofthe abdomen with abrasive paper) -Women connected to external or implanted electrical stimulators -Women with language barrier and mental disorders

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: As a first primary endpoint, success rate, accuracy, and reliability of FHR monitored by NFMS will be compared with FHR monitored by gold standard FSE.

Secondary

MeasureTime frame
Secondary endpoints: success rate, accuracy, and reliability of MHR monitored by NFMS will be compared with MHR monitored by standard care such as Doppler pulse measurements provided by abdominal pulse oximetry, incorporated in the TOCO button, or finger pulse oximetry. The UA monitored by NFMS will be compared with the one monitored by standard care such as tocodynamometer (TOCO) or intrauterine pressure catheter (IUPC).

Countries

Germany, Netherlands

Contacts

Public ContactM.E.M.H. Westerhuis

Catharina Ziekenhuis

researchgyn@catharinaziekenhuis.nl040-2399300

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 10, 2026